IBM
57
2
NOC
47
4
NEM
49
3
ALLE
39
-2
SYK
40
-4
NDAQ
66
2
BIIB
40
-3
BDX
54
-2
ADSK
53
4
BRK.B
49
2
VTR
55
-5
XYL
39
6
SWK
45
6
MSI
50
-5
AAPL
58
2
RF
70
3
CTAS
37
-2
MUR
44
2
UAL
72
-2
AEE
74
-2
IBM
57
2
NOC
47
4
NEM
49
3
ALLE
39
-2
SYK
40
-4
NDAQ
66
2
BIIB
40
-3
BDX
54
-2
ADSK
53
4
BRK.B
49
2
VTR
55
-5
XYL
39
6
SWK
45
6
MSI
50
-5
AAPL
58
2
RF
70
3
CTAS
37
-2
MUR
44
2
UAL
72
-2
AEE
74
-2
Financhill
Back

Innovative Eyewear 10K Form

Sell
23

LUCY
Innovative Eyewear

Last Price:
$2.80
Seasonality Move:
34.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LUCY News And Ratings

See the #1 stock for the next 7 days that we like better than LUCY

LUCY Financial Statistics

Sales & Book Value

Annual Sales: $1.6M
Cash Flow: $-2M
Price / Cash Flow: 0
Annual Sales: $3.72
Price / Book: 0.82

Profitability

EPS (TTM): -6.73060
Net Income (TTM): $-7.8M
Gross Margin: $215.2K
Return on Equity: -105.44%
Return on Assets: -96.3%

Innovative Eyewear Earnings Forecast

Key Innovative Eyewear Financial Ratios

  • The Gross Profit Margin over the past 6 years for LUCY is 13.15%.
  • The Selling, General & Administrative Expenses for LUCY have been equal to 438.73% of Gross Profit Margin.
  • The Research & Development expenses have been 50.07% of Revenue.
  • The Net Earning history of LUCY is -474.60% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Innovative Eyewear Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: LUCY
Website: lucyd.co

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 12.52
Quick Ratio: 10.38

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 4.41

LUCY Technical Analysis vs Fundamental Analysis

Sell
23
Innovative Eyewear (LUCY) is a Sell

Is Innovative Eyewear a Buy or a Sell?